Publication | Closed Access
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
811
Citations
23
References
1999
Year
Hematological MalignancyCyclin-dependent KinasesChinese Antileukaemia MedicineActive ConstituentMedicineMalignant Blood DisorderAnti-cancer AgentPharmacologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1